Showing results (481-490 of 733) with videos related to
Sort By:
Pageof 74
Nature|March 1, 2013
Replication stress links structural and numerical cancer chromosomal instabilityRebecca A Burrell, Sarah E McClelland, David Endesfelder, et al.The Journal of Pathology|September 29, 2011
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy inductionAlvin J X Lee, Rebecca Roylance, Jil Sander, et al.Proceedings of the National Academy of Sciences of the United States of America|February 13, 2023
An HLA-G/SPAG9/STAT3 axis promotes brain metastasesBlessing Iquo Bassey-Archibong, Chirayu Rajendra Chokshi, Nikoo Aghaei, et al.Nature Cancer|January 10, 2024
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinomaXiaoxi Pan, Khalid AbdulJabbar, Jose Coelho-Lima, et al.Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.JAMA Oncology|June 30, 2017
Nivolumab for Patients With Advanced Melanoma Treated Beyond Progression: Analysis of 2 Phase 3 Clinical TrialsGeorgina V Long, Jeffrey S Weber, James Larkin, et al.Molecular Cancer Therapeutics|October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell CarcinomaVictoria L Bridgeman, Elaine Wan, Shane Foo, et al.Cancer Discovery|February 22, 2024
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell CarcinomaToni K Choueiri, Amber C Donahue, David A Braun, et al.Journal for Immunotherapy of Cancer|November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.Cancer Immunology Research|August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced MelanomaF Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.Pageof 74